Simplify Logo

Full-Time

QC Associate I

1st shift, Wednesday to Saturday

Confirmed live in the last 24 hours

ElevateBio

ElevateBio

201-500 employees

Develops and manufactures cell and gene therapies

Biotechnology
Healthcare

Entry, Junior

Waltham, MA, USA

Category
Bioinformatics
Biology Lab & Research
Biology & Biotech
Requirements
  • Bachelor’s, or Master’s, degree in a technical discipline (Biology/Molecular Biology/Biochemistry/Chemistry or related field). 1-5 years of experience with a Bachelor’s, 1-3 years with a Master’s.
  • Experience working in a GMP setting preferred.
  • Experience with cell and gene therapy test methodologies (i.e. PCR, Flow Cytometry, ELISA, cell culture, cell-based assays).
  • Excellent organizational skills and attention to detail.
  • Ability to work independently as well as communicate and collaborate with scientific/technical personnel.
  • Experience performing laboratory investigations.
  • Knowledge of GMP, SOPs, and Quality System processes.
  • Experience working with electronic systems (LIMS, CMMS, QMS, ERP) is a plus.
Responsibilities
  • Perform routine testing using established test methods, analyze the results, and record/report the data.
  • Perform peer-review of data records and testing reports.
  • Assist with investigating and reviewing testing excursions, including deviations, CAPAs and OOSs.
  • Collaborate with other QC functions to ensure all testing is completed within established timelines.
  • Share responsibility with peers to manage inventory and reagents, and perform maintenance and other daily lab operations.
  • Work cross-functionally with Analytical Development and other QC functions to assist in the qualification of developed assays.
  • Assist in drafting and/or editing procedures for testing and/or equipment.

ElevateBio focuses on biotechnology, specifically in the cell and gene therapy market. They use proprietary technologies like gene editing and induced pluripotent stem cells (iPSC) to develop and manufacture therapies. Their integrated ecosystem allows them to support the entire process from discovery to commercialization, setting them apart from competitors. The goal is to advance scientific breakthroughs and deliver a wide range of effective therapies.

Company Stage

Series D

Total Funding

$1.2B

Headquarters

Waltham, Massachusetts

Founded

2017

Growth & Insights
Headcount

6 month growth

24%

1 year growth

19%

2 year growth

34%
Simplify Jobs

Simplify's Take

What believers are saying

  • ElevateBio's recent $401 million Series D financing round, led by prominent investors, positions the company for accelerated growth and innovation.
  • The collaboration with the University of Pittsburgh to build the BioForge facility will significantly expand their manufacturing capabilities and technological infrastructure.
  • Their partnerships and commercialization efforts, including potential earnouts up to $2.35 billion with Novo Nordisk, offer substantial financial and developmental opportunities.

What critics are saying

  • The highly competitive biotechnology sector requires continuous innovation and investment to maintain a leading position.
  • Dependence on strategic partnerships and collaborations may pose risks if these relationships encounter challenges or fail to deliver expected outcomes.

What makes ElevateBio unique

  • ElevateBio's integrated ecosystem of technologies and capabilities allows them to discover, develop, manufacture, and commercialize a broad spectrum of cell and gene therapies, setting them apart from competitors who may only focus on one aspect of the process.
  • Their strategic partnerships with industry leaders like Novo Nordisk and Kyverna Therapeutics enhance their technological and therapeutic development capabilities.
  • The company's proprietary technologies, such as gene editing and induced pluripotent stem cell (iPSC) platforms, provide a competitive edge in the biotechnology market.

Help us improve and share your feedback! Did you find this helpful?